摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

苯并[b]噻吩-5-甲腈,2-甲酰基- | 105191-42-2

中文名称
苯并[b]噻吩-5-甲腈,2-甲酰基-
中文别名
——
英文名称
2-Formylbenzothiophen-5-carbonitril
英文别名
5-cyanobenzo[b]thiophene-2-carbaldehyde;2-Formylbenzo[b]thiophene-5-carbonitrile;2-formyl-1-benzothiophene-5-carbonitrile
苯并[b]噻吩-5-甲腈,2-甲酰基-化学式
CAS
105191-42-2
化学式
C10H5NOS
mdl
——
分子量
187.222
InChiKey
WCTIDZVDTNFABJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    389.6±22.0 °C(Predicted)
  • 密度:
    1.35±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    69.1
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:152c5c4a787405a8be211b24bfc43a00
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors
    摘要:
    A series of benzoxazinone derivatives was designed and synthesized as factor Xa inhibitors. We demonstrated that the naphthyl moiety in the aniline-based compounds I and 2 can be replaced with benzene-fused heterobicycles and biaryls to give factor Xa inhibitors with improved trypsin selectivity. The P4 modifications lead to monoamidines which are moderately active. The benzoxazinones 41-45 are potent against factor Xa, retain the improved trypsin selectivity of the corresponding aniline-based compounds, and show strong antithrombotic effect dose responsively. (C) 2002 Published by Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(02)00927-7
  • 作为产物:
    描述:
    5-氰基-2-氟苯甲醛 在 sodium tetrahydroborate 、 TEA 、 碳酸氢钠 、 calcium iodide 、 2-碘酰基苯甲酸 作用下, 以 四氢呋喃二甲基亚砜 为溶剂, 生成 苯并[b]噻吩-5-甲腈,2-甲酰基-
    参考文献:
    名称:
    Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors
    摘要:
    A series of benzoxazinone derivatives was designed and synthesized as factor Xa inhibitors. We demonstrated that the naphthyl moiety in the aniline-based compounds I and 2 can be replaced with benzene-fused heterobicycles and biaryls to give factor Xa inhibitors with improved trypsin selectivity. The P4 modifications lead to monoamidines which are moderately active. The benzoxazinones 41-45 are potent against factor Xa, retain the improved trypsin selectivity of the corresponding aniline-based compounds, and show strong antithrombotic effect dose responsively. (C) 2002 Published by Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(02)00927-7
点击查看最新优质反应信息

文献信息

  • Aromatic amidine derivatives and salts thereof
    申请人:Daiichi Pharmaceutical Co., Ltd.
    公开号:US05576343A1
    公开(公告)日:1996-11-19
    An anticoagulant agent which comprises, as an active ingredient, an aromatic amidine derivative represented by the following general formula (1) or a salt thereof: ##STR1## wherein the group represented by ##STR2## is a group selected from indolyl, benzofuranyl, benzothienyl, benzimidazolyl, benzoxazolyl, benzothiazolyl, naphthyl, tetrahydronaphthyl and indanyl; X is a single bond, an oxygen atom, a sulfur atom or a carbonyl group; and Y is a saturated or unsaturated 5- or 6-membered heterocyclic moiety or cyclic hydrocarbon moiety optionally having a substituent group, an amino group optionally having a substituent group or an aminoalkyl group optionally having a substituent group. The inventive compound has a high anticoagulant capacity based on its excellent FXa inhibition activity.
    一种抗凝剂,其包括作为活性成分的芳香胺基衍生物,其由以下一般式(1)或其盐所表示:##STR1## 其中由##STR2##表示的基团是从吲哚基,苯并呋喃基,苯并噻吩基,苯并咪唑基,苯并噁唑基,苯并噻唑基,萘基,四氢萘基和吲哚基中选择的基团;X是单键,氧原子,硫原子或羰基;Y是饱和或不饱和的5-或6-成员杂环基团或环烃基团,可选地具有取代基团,可选地具有取代基团的氨基团或可选地具有取代基团的氨基烷基团。这种创新化合物具有基于其出色的FXa抑制活性的高抗凝能力。
  • Dann, Otto; Char, Helmut; Fleischmann, Paul, Liebigs Annalen der Chemie, 1986, # 3, p. 438 - 455
    作者:Dann, Otto、Char, Helmut、Fleischmann, Paul、Fricke, Helmut
    DOI:——
    日期:——
  • DANN, O.;CHAR, H.;FLEISCHMANN, P.;FRICKE, H., LIEBIGS ANN. CHEM., 1986, N 3, 438-455
    作者:DANN, O.、CHAR, H.、FLEISCHMANN, P.、FRICKE, H.
    DOI:——
    日期:——
  • US5576343A
    申请人:——
    公开号:US5576343A
    公开(公告)日:1996-11-19
  • US5620991A
    申请人:——
    公开号:US5620991A
    公开(公告)日:1997-04-15
查看更多

同类化合物